Journal profile

Lymphatic research and biology

Publisher: SAGE Publications
ISSN1539-6851 | 1557-8585 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.93
Citation rate 1.94 235 total citations
h5-index 21 h5 depth signal
Cited share 59.8% 76 of 127
Total citations 235 Citation footprint
Metric signal 1.84 External metric anchor
Self-citation 8.5% 20 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 220
Turkey 75
Japan 73
United Kingdom 54
Australia 53

Citing Fields of Research

Breast Cancer 356
Wounds & Ulcers 152
Diagnostic & Therapeutic Ultrasound 119
Oncology 103
Health Education & Remote Healthcare 53

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 1,247 Articles tracked across the journal lifetime
Indexed publication set 127 76 cited publications
Last 12 months 49 4.1 publications/month
Open access share 4.1% 2 OA publications in the last year
Leading citing country United States 220 citing publications
Leading citing field Breast Cancer 356 citing publications
Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, 2003-
PubMed
v1n1, 2003-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Breast Cancer

Issuing & Sponsoring Bodies

Contributor
Lymphatic Research Foundation

Broad Categories

Allergy and Immunology Breast Cancer

MeSH Descriptors

Lymphatic Diseases Lymphatic System Research

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

04
Sukriye Cansu Gultekin, Zeynep Gulsum Guc, Faruk Recep Ozalp et al.
Background: Although several patient-reported outcome measures (PROMs) exist to assess health-related quality of life (HRQoL) in patients with breast cancer-related lymphedema (BCRL), most lack sufficient patient input. The LYMPH-Q Upper...
06
Aysel Ozge Kemer, Esra Uzelpasaci, Turkan Akbayrak et al.
Background: To assess the reliability and validity of the Turkish version of the lymphedema symptom intensity and distress survey-arm (LSIDS-A) in breast cancer-related lymphedema (BCRL). Methods: The LSIDS-A was translated and culturall...
07
Shayan M. Sarrami, James E. Fanning, Michael Mazarei et al.
Background: Lymphedema remains a chronic, progressive, and currently incurable condition. Historically, surgical treatment options were severely limited and largely palliative. Over recent decades, however, advances in the understanding ...

Bibliographical & Catalog Notes

Title from cover.

Also issued online.

Official journal of the Lymphatic Research Foundation.

v.1, no. 1 (Mar. 2003)20041129 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper